Wednesday , June 20 2018
Home / Letter From The Editor (page 50)

Letter From The Editor

Letter from the Editor #729

On Friday morning after I got done with a 40 mile bike ride with our local club, we were sitting and talking at our favorite coffee shop when my phone rang. It was a family friend who wanted to talk about her husband’s medications for diabetes. He had been referred …

Read More »

Editor’s Note, DCMS #188

Each and every month we have been providing you with the best information on GLP-1 agonists with our monthly special editions. Many of you send me emails thanking us for the information and how you have been able to incorporate the knowledge into your practice. This week our Clinical Text …

Read More »

Letter from the Editor #728

We have a really interesting item this week that bears reading more than once. Item #4 talks about using glimepiride with patients who are on insulin and how this may be safer and and better than adding more insulin. This article could be turned around to say we should start …

Read More »

Letter from the Editor #727

Often times our patients get so much information that they get frustrated and just give up. This means all our efforts go to waste and both the patient and practitioner are unhappy. Our health and wellness guru Dr. Sheri Colberg has been working with patients for the last 20 years …

Read More »

Editor’s Note, DCMS #186

Most clinicians focus on fasting glucose levels to prevent the complications of diabetes. What if there was a generic diabetes medication available that would lower ppg and cardiovascular risk and had almost no chance of causing hypoglycemia? If you want to find out what that medication is then check out …

Read More »

Letter from the Editor #726

Most of us have seen the benefits of testosterone supplementation for our patients with diabetes. We most often think of the increased muscle mass, and libido in our prescribing decision. This week a new study shows additional benefits of replacement therapy, including improvement in….. See this week’s Item #6 for the …

Read More »

Editor’s Note, DCMS #185

U-500 is a small word that causes a lot of fear in the hearts of some physicians, pharmacists and patients. This regular insulin marketed by Eli Lilly as Humulin R U-500 is without a doubt the hardest insulin to work with. Converting doses, figuring days supply, and writing directions can …

Read More »